These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1158 related items for PubMed ID: 17063274

  • 1. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T, Yuen S, Kasami M, Uchida Y.
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
    Jiang Y, Lou J, Wang S, Zhao Y, Wang C, Wang D.
    PLoS One; 2014 Mar; 9(6):e99669. PubMed ID: 24927476
    [Abstract] [Full Text] [Related]

  • 4. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
    Linda A, Zuiani C, Londero V, Di Gaetano E, Dal Col A, Girometti R, Bazzocchi M.
    Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
    [Abstract] [Full Text] [Related]

  • 5. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K, Schrading S, Hansen NL, Barabasch A, Kuhl CK.
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [Abstract] [Full Text] [Related]

  • 6. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [Abstract] [Full Text] [Related]

  • 7. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5th edition of BI-RADS.
    Eun NL, Son EJ, Gweon HM, Youk JH, Kim JA.
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
    Li E, Li J, Song Y, Xue M, Zhou C.
    PLoS One; 2014 Aug; 9(11):e111217. PubMed ID: 25365327
    [Abstract] [Full Text] [Related]

  • 9. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications.
    Uematsu T, Kasami M, Yuen S.
    Breast Cancer; 2008 Aug; 15(4):291-7. PubMed ID: 18288569
    [Abstract] [Full Text] [Related]

  • 10. The value of dynamic contrast enhanced breast MRI in mammographically detected BI-RADS 5 microcalcifications.
    Houserkova D, Prasad SN, Svach I, Kucerova L, Duskova M, Bucil J, Sisola I, Zlamalova N, Svebisova H.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):107-15. PubMed ID: 18795084
    [Abstract] [Full Text] [Related]

  • 11. [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication].
    Siegmann KC, Wersebe A, Fischmann A, Fersis N, Vogel U, Claussen CD, Müller-Schimpfle M.
    Rofo; 2003 Jan; 175(1):99-104. PubMed ID: 12525989
    [Abstract] [Full Text] [Related]

  • 12. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 13. MRI and comparison mammography: a worthy diagnostic alliance for breast microcalcifications?
    Brnic D, Brnic D, Simundic I, Vanjaka Rogosic L, Tadic T.
    Acta Radiol; 2016 Apr; 57(4):413-21. PubMed ID: 25995311
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
    Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E.
    Cancer; 2004 Feb 15; 100(4):710-4. PubMed ID: 14770425
    [Abstract] [Full Text] [Related]

  • 15. Breast 3 T-MR imaging: indication for stereotactic vacuum-assisted breast biopsy.
    Yamamoto N, Yoshizako T, Yoshikawa K, Itakura M, Maruyama R, Kitagaki H.
    Springerplus; 2014 Feb 15; 3():481. PubMed ID: 25932356
    [Abstract] [Full Text] [Related]

  • 16. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K, Mori N, Schacht DV, Sheth D, Karczmar GS, Newstead GM, Abe H.
    J Magn Reson Imaging; 2017 Dec 15; 46(6):1738-1747. PubMed ID: 28295791
    [Abstract] [Full Text] [Related]

  • 17. Positive predictive value of BI-RADS MR imaging.
    Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C.
    Radiology; 2012 Jul 15; 264(1):51-8. PubMed ID: 22589320
    [Abstract] [Full Text] [Related]

  • 18. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B, Dietzel M, Baltzer PA.
    PLoS One; 2017 Jul 15; 12(11):e0188679. PubMed ID: 29190656
    [Abstract] [Full Text] [Related]

  • 19. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.
    Bent CK, Bassett LW, D'Orsi CJ, Sayre JW.
    AJR Am J Roentgenol; 2010 May 15; 194(5):1378-83. PubMed ID: 20410428
    [Abstract] [Full Text] [Related]

  • 20. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
    Friedlander LC, Roth SO, Gavenonis SC.
    Radiology; 2011 Nov 15; 261(2):421-7. PubMed ID: 21900618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.